BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21661760)

  • 1. Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
    Judd WR; Slattum PM; Hoang KC; Bhoite L; Valppu L; Alberts G; Brown B; Roth B; Ostanin K; Huang L; Wettstein D; Richards B; Willardsen JA
    J Med Chem; 2011 Jul; 54(14):5031-47. PubMed ID: 21661760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    Go ML; Leow JL; Gorla SK; Schüller AP; Wang M; Casey PJ
    J Med Chem; 2010 Oct; 53(19):6838-50. PubMed ID: 20809634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
    Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML
    Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx.
    Buchanan MS; Carroll AR; Fechner GA; Boyle A; Simpson M; Addepalli R; Avery VM; Forster PI; Guymer GP; Cheung T; Chen H; Quinn RJ
    Phytochemistry; 2008 Jun; 69(9):1886-9. PubMed ID: 18466935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
    Al-Tel TH
    Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.
    Buchanan MS; Carroll AR; Fechner GA; Boyle A; Simpson MM; Addepalli R; Avery VM; Hooper JN; Su N; Chen H; Quinn RJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6860-3. PubMed ID: 17964784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
    Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and biological evaluation of pederin, psymberin, and highly potent analogs.
    Wan S; Wu F; Rech JC; Green ME; Balachandran R; Horne WS; Day BW; Floreancig PE
    J Am Chem Soc; 2011 Oct; 133(41):16668-79. PubMed ID: 21902245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
    Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
    Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
    Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
    J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
    Shallal HM; Russu WA
    Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine.
    Salaski EJ; Krishnamurthy G; Ding WD; Yu K; Insaf SS; Eid C; Shim J; Levin JI; Tabei K; Toral-Barza L; Zhang WG; McDonald LA; Honores E; Hanna C; Yamashita A; Johnson B; Li Z; Laakso L; Powell D; Mansour TS
    J Med Chem; 2009 Apr; 52(8):2181-4. PubMed ID: 19309081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
    Castellano S; Kuck D; Viviano M; Yoo J; López-Vallejo F; Conti P; Tamborini L; Pinto A; Medina-Franco JL; Sbardella G
    J Med Chem; 2011 Nov; 54(21):7663-77. PubMed ID: 21958292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and structure-activity relationship of N-phenyl-1H-pyrazolo[3,4-b]quinolin-4-amines as a new series of potent apoptosis inducers.
    Zhang HZ; Claassen G; Crogran-Grundy C; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem; 2008 Jan; 16(1):222-31. PubMed ID: 17950608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
    Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
    Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.